Clinical Trial Update: Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating adjunctive methylphenidate extended-release for improving functional and cognitive outcomes in schizophrenia (and schizoaffe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Methylphenidate ER (methylphenidate extended-release)

Snippet

Sponsor: The Royal Ottawa Mental Health Centre | Conditions: Schizophrenia Schizoaffective | Phase 2 | Status: COMPLETED